National Cancer Institute; Notice of Closed Meetings, 7615-7616 [E9-3313]

Download as PDF mstockstill on PROD1PC66 with NOTICES Federal Register / Vol. 74, No. 31 / Wednesday, February 18, 2009 / Notices Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 435– 2359, shayiqr@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, HIV/ AIDS Vaccines Study Section. Date: March 11, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Suites Palm Springs, 285 North Palm Canyon Drive, Palm Springs, CA 92262. Contact Person: Mary Clare Walker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5208, MSC 7852, Bethesda, MD 20892, (301) 435– 1165, walkermc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Physiology and Pathobiology of Musculoskeletal, Oral, and Skin Systems. Date: March 12, 2009. Time: 8 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2183, MSC 7818, Bethesda, MD 20892, 301–435– 2365, aitouchea@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Software Maintenance and Extension. Date: March 16–17, 2009. Time: 6 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Quincy Hotel, 1823 L Street, NW., Washington, DC 20036 (Virtual Meeting). Contact Person: George W. Chacko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5170, MSC 7849, Bethesda, MD 20892, 301–435– 1245, chackoge@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Molecular Probes for Microscopy of Cells. Date: March 18–19, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Amy L. Rubinstein, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm 5152 MSC 7844, Bethesda, MD 20892, 301–435–1159, rubinsteinal@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Infectious Diseases Microbiology Fellowships. Date: March 19–20, 2009. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 17:45 Feb 17, 2009 Jkt 217001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alexander D. Politis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 10, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3300 Filed 2–17–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 2, 2009, 12 p.m. to February 2, 2009, 1 p.m., Mayflower Park Hotel, 405 Olive Way, Seattle, WA, 98101 which was published in the Federal Register on January 16, 2009, 74 FR 3064–3065. The meeting will be held February 27, 2009, from 2 p.m. to 4 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: February 10, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3304 Filed 2–17–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 24, 2009, 11 a.m. to February 25, 2009, 12 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on February 5, 2009, 74 FR 6166–6169. The meeting title has been changed to ‘‘Brain Injury Member SEP’’. The meeting is closed to the public. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 7615 Dated: February 10, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3305 Filed 2–17–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, R13 Conference Grant Review. Date: March 19, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Room 8041, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd. Room 8041, Bethesda, MD 20892, (301) 402–0371, sahab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Quantitative Tissue Imaging for Clinical Diagnosis and Treatment. Date: March 19, 2009. Time: 12:01 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6130 Executive Blvd., Conference Room J, Rockville, MD 20852 (Telephone Conference Call) Contact Person: Michael B. Small, PhD, Scientific Review Officer, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 20892–8328, 301–402–0996, smallm@mail.nih.gov. E:\FR\FM\18FEN1.SGM 18FEN1 7616 Federal Register / Vol. 74, No. 31 / Wednesday, February 18, 2009 / Notices mstockstill on PROD1PC66 with NOTICES Name of Committee: National Cancer Institute Special Emphasis Panel, Novel and Improved Methods for Detecting Epigenetic Modifications. Date: March 26, 2009. Time: 9 a.m. to 2 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Suite 800, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Ilda M. Mckenna, PhD, Scientific Review Officer, Research Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard Room 8111, Bethesda, MD 20892, 301–496–7481, mckennai@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Multifunctional Therapeutics Based on Nanotechnology (Phase II). Date: April 7, 2009. Time: 8:30 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: M Street Renaissance Hotel— Marriott, 1143 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Irina V. Gordienko, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard Room 7073, Bethesda, MD 20892, 301–594–1566. gordienkoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA). Date: April 9, 2009. Time: 2 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8041, Bethesda, MD 20892, (301) 402–0371, sahab@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Name of Committee: National Center for Research Resources Special Emphasis Panel; Research Web Portal. Date: March 19, 2009. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Guo Zhang, MD, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Rm. 1064, Bethesda, MD 20892–4874, 301–435– 0812, zhanggu@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; Conference Grants 1. Date: March 19, 2009. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Lee Warren Slice, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, Bethesda, MD 20892, 301–435–0965. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: February 10, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3313 Filed 2–17–09; 8:45 am] Dated: February 11, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3435 Filed 2–17–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P VerDate Nov<24>2008 17:45 Feb 17, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Center for Research Resources; Notice of Closed Meetings National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders B. Date: February 26–27, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Catamaran Resort Hotel Spa, 3999 Mission Boulevard, San Diego, CA 92109. Contact Person: Ernest W Lyons, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301– 496–4056. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders C. Date: February 26–27, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Portofino Hotel & Yacht Club, 260 Portofino Way, Redondo Beach, CA 90277. Contact Person: William C. Benzing, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 3208, MSC 9529, Bethesda, MD 20892, (301) 496–0660, benzingw@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Neurological Sciences Training Initial Review Group, NST–2 Subcommittee. E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 74, Number 31 (Wednesday, February 18, 2009)]
[Notices]
[Pages 7615-7616]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3313]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R13 Conference Grant Review.
    Date: March 19, 2009.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8041, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, 
Program Coordination and Referral Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd. 
Room 8041, Bethesda, MD 20892, (301) 402-0371, sahab@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Quantitative Tissue Imaging for Clinical Diagnosis and 
Treatment.
    Date: March 19, 2009.
    Time: 12:01 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6130 Executive Blvd., 
Conference Room J, Rockville, MD 20852 (Telephone Conference Call)
    Contact Person: Michael B. Small, PhD, Scientific Review 
Officer, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8127, Bethesda, MD 20892-8328, 301-402-0996, smallm@mail.nih.gov.


[[Page 7616]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Novel and Improved Methods for Detecting Epigenetic 
Modifications.
    Date: March 26, 2009.
    Time: 9 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Suite 800, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Ilda M. Mckenna, PhD, Scientific Review Officer, 
Research Training Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard Room 8111, 
Bethesda, MD 20892, 301-496-7481, mckennai@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Multifunctional Therapeutics Based on Nanotechnology (Phase 
II).
    Date: April 7, 2009.
    Time: 8:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: M Street Renaissance Hotel--Marriott, 1143 New Hampshire 
Avenue, NW., Washington, DC 20037.
    Contact Person: Irina V. Gordienko, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard Room 
7073, Bethesda, MD 20892, 301-594-1566. gordienkoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Exceptional, Unconventional Research Enabling Knowledge 
Acceleration (EUREKA).
    Date: April 9, 2009.
    Time: 2 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, 
Program Coordination and Referral Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8041, Bethesda, MD 20892, (301) 402-0371, sahab@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3313 Filed 2-17-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.